Biomarin Pharmaceutical (BMRN) EPS (Basic) (2009 - 2026)
Biomarin Pharmaceutical (BMRN) recorded quarterly EPS (Basic) of $0.55 in Q1 2026, up 329.17% on a QoQ basis from -$0.24 in Q4 2025, and down 43.3% year-over-year from $0.97 in Q1 2025.
Biomarin Pharmaceutical (BMRN) EPS (Basic) (2009 - 2026) Analysis & Trends
Biomarin Pharmaceutical has disclosed EPS (Basic) across 18 years of filings, most recently posting $0.55 for Q1 2026.
- Quarterly EPS (Basic) fell 43.3% year-over-year to $0.55 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 (down 49.09% YoY) and the FY2025 annual result came in at $1.82, down 19.11% from the prior year.
- EPS (Basic) rose to $0.55 in Q1 2026, from -$0.24 in the prior quarter.
- Over five years, EPS (Basic) peaked at $1.25 in Q2 2025 and troughed at -$0.24 in Q4 2025.
- A 5-year average of $0.37 and a median of $0.3 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) soared 1200.0% — and 2025, when it plunged 136.36%.
- Tracing BMRN's EPS (Basic) over 5 years: stood at -$0.01 in 2022, then surged by 1200.0% to $0.11 in 2023, then surged by 500.0% to $0.66 in 2024, then tumbled by 136.36% to -$0.24 in 2025, then jumped by 329.17% to $0.55 in 2026.
- Business Quant data shows BMRN's EPS (Basic) at $0.55 in Q1 2026, -$0.24 in Q4 2025, and -$0.16 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Biomarin Pharmaceutical | 10.52 Bn | 8.29 Bn | 571.21 Mn | 0.55 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.55 |
| Dec 31, 2025 | -0.24 |
| Sep 30, 2025 | -0.16 |
| Jun 30, 2025 | 1.25 |
| Mar 31, 2025 | 0.97 |
| Dec 31, 2024 | 0.66 |
| Sep 30, 2024 | 0.56 |
| Jun 30, 2024 | 0.56 |
| Mar 31, 2024 | 0.47 |
| Dec 31, 2023 | 0.11 |
| Sep 30, 2023 | 0.21 |
| Jun 30, 2023 | 0.30 |
| Mar 31, 2023 | 0.27 |
| Dec 31, 2022 | -0.01 |
| Sep 30, 2022 | -0.04 |
| Jun 30, 2022 | 0.15 |
| Mar 31, 2022 | 0.66 |
| Dec 31, 2021 | -0.32 |
| Sep 30, 2021 | -0.20 |
| Jun 30, 2021 | 0.07 |